CECLOR
LOE ApproachingNDAORALFOR SUSPENSION
Approved
Apr 1979
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 13h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CECLOR is an oral suspension antibiotic approved in 1979 by Eli Lilly, representing a mature small-molecule product in the cephalosporin class. The drug treats bacterial infections across multiple indications via oral delivery, making it accessible for outpatient and pediatric populations. Mechanism of action involves beta-lactam cell wall inhibition, typical of its antibiotic class.
LOE Approaching
Product approaching loss of exclusivity with low competitive pressure (30/100), signaling reduced team investment and focus on managed decline rather than growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Zero linked job openings reflect this product's mature, declining commercial status; career growth is limited to operational and defensive roles managing generic transition. Professionals seeking dynamic brand-building or clinical innovation should avoid assignment to this franchise.
Brand Manager (Maintenance)Sales Representative (Generic Transition)
Worked on CECLOR at Eli Lilly and Company? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.